Please assess the completion status of the following clinical trial:

Trial Title: Low Doses of Cholestyramine in the Treatment of Hyperthyroidism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with newly diagnosed hyperthyroid Graves' disease~Exclusion Criteria:~* If the patient had been treated previously~* diabetes, kidney, or liver disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): Cholestyramine 2g BID, Methimazole 10mg TID, and Propranolol 20mg BID
- II (Type: EXPERIMENTAL): Cholestyramine 1g BID, Methimazole 10mg TID, and Propranolol 20mg BID
- III (Type: PLACEBO_COMPARATOR): Placebo powder 1g BID, Methimazole 10mg TID, and Propranolol 20mg BID

Based on this trial design, predict the completion outcome and termination type (if applicable).